Finland· FI-REL-REL60214
Ducressa
A dexamethason mit antiinfektiva product containing dexamethasone sodium phosphate + levofloxacin hemihydrate, registered in Finland by Orifarm Oy. The same ATC class is registered in 11 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Dexamethason mit antiinfektiva is registered in 11 of 19 countries.
Countries holding a registration under ATC S01CA01 (dexamethason mit antiinfektiva), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Dexamethason mit antiinfektiva · ATC S01CA01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Dexamethasone sodium phosphate + Levofloxacin hemihydrate
- Manufacturer
- Orifarm Oy
- Country
- Finland (FI)
- ATC code
- S01CA01
- ATC class
- Dexamethason mit Antiinfektiva
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 1
1 priced- fi_myyntilupa4550735 mlEUR 19.75
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dexamethason mit antiinfektiva in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Ducressa
- Czechia · Ducressa
- Germany · Ducressa Md
- Denmark · Ducressa
- Spain · Ducressa
- France · Dugressa
- United Kingdom (Northern Ireland) · Ducressa Md
- Hungary · Ducressa
- Iceland · Ducressa
- Liechtenstein · Ducressa
- Latvia · Ducressa
- Poland · Ducressa Md
- Portugal · Ducressa Md
- Slovakia · Ducressa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f4e85fb1-db9e-4a4d-b85c-8a085b612925 GET /v1/drugs/f4e85fb1-db9e-4a4d-b85c-8a085b612925?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "silmätipat, liuos",
"route": "Silmän pinnalle",
"ddd_unit": null,
"strength": "1 mg/ml + 5 mg/ml",
"atc_label": "deksametasoni ja mikrobilääkkeet",
"ma_number": "41153",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL60214",
"authorised_at": "2023-02-02"
}See everything about dexamethason mit antiinfektiva.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.